DiagnosticIs Now On Sale! You can Buy Cheap & Low Prices on
PHion Balance Diagnostic Ph Test Strips, 4.5 - 9.0 ph Range, 90-Count
Discount. Read More Reviews. ...
- Super sensitive and accurate
- Easier to read than litmus paper
- Gives you an extremely accurate reading of how acidic or alkaline your tissues really are
- Measure tight 0.25 increments to know exactly what your pH is
- Can test both urine and saliva to give you the most complete picture of your pH
- Economical. pHion Diagnostic pH Test Strips are more accurate, more versatile, and easier to read than litmus paper, yet theyre surprisingly affordable
- No guesswork. Because pHion Diagnostic pH Test Strips measure tight 0.25 increments, youll know exactly what your pH is
- Super-sensitive pHion Diagnostic pH Test Strips give you an extremely accurate reading of how acidic or alkaline your tissues really are
- Unlike regular pH paper, the pHion Diagnostic pH Test Strips' single pad indicator is super easy to read
- Versatile. pHion Diagnostic pH Test Strips can test both urine and saliva to give you the most complete picture of your pH
Listprice :$ 15.30
our comprehensive market report on changes in abundance in cancer prevention industry. Developments, both new year on how the marketing of service, testing and pharmacogenomics tissue microarrays showed an increased presence. Some companies that have promised much in the past, no results. And newcomers have the box.
These changes are recorded and Kalorama Information, the worldwide market for cancer diagnostics, the fourth run. Edition. This report from Kalorama analyst Shara Rosen writes diagnostic, detailed market includes the following segments DIV for use in cancer diagnosis:
• Histology / Cytology
• • immunoassays
flow cytometry • Rapid tests
• molecular analysis
• • Tissue Arrays circulating tumor cells
• Pharmacodiagnostics a test effective diagnostic for cancer prevention are obviously needed more than ever. As a cancer diagnosis can be better managed several advanced features, including pharmacodiagnostics to adapt the targeted treatment of patients and monitoring of diseases such as cancer is within the area of ​​chronic diseases treatable. Kalorama Information, the worldwide market for cancer diagnostics is the fourth edition of Kalorama fourth time was active in a comprehensive study on the status of this important diagnostic market. Apparent in the market data in this report, readers will find:
• Lab Based Immunoassay cancer test sales
• The volume of Pap
• Cancer statistics in the world
• •
POC testing reagents of DNA for cancer detection
• CTC testing markets
• Biochip Innovations • New companies with innovative concepts
• "backward" societies that are not expectations br / Met> • High in protein and molecular markers used in immunohistochemistry
under investigation • Biomarkers • Mergers and acquisitions • State
pharmacogenomic tests
• Microarray Markets in clinical laboratories
• lists of suppliers and contains the main products
• Medical supplies market
This report analyzes the market testing as follows: The profile of the cancer, the CTC, the fecal occult blood, PSA, H. pylori, IHC, ISH and tests for certain types of cancer: bladder cancer •
• Breast cancer Cervical cancer Colon cancer • •
• Lung cancer Ovarian cancer • • prostate cancer
This latest edition of Kalorama Information study takes a new look on all these changes, both qualitatively and quantitatively. The report provides revenue forecasts and growth until 2014 and, as in the previous edition, the market analyzed in two ways:
• tests for certain cancers and cancer
• IVD tests in segments Specific />
CHAPTER ONE contents:. Summary
Introduction Scope and Methodology Size and growth segments of the market test
Market Trends geographical distribution rate
mortality
Revolutionary Therapeutics
Factor Doctor consumer prices Hall
Chapter Two: Introduction
context pharmacogenomics testing service marketing
- point management diagnosis and therapy of view
CHAPTER THREE: Market trends in the commercialization of diagnostic tests for cancer " br />
broad demographic of cancer, a cancer tests worldwide phenomenon in the world
testing and government-supported programs
United States of America International
Europe
Mexico reimbursement and commercialization of new tests
Test Services - Route de l'Innovation cancer
Table 3-3 Regulatory requirements for new products
strategic alliances and partnerships personalized medical advances
gene patents and test marketing
CHAPTER FOUR: Technology Trends
background biomarker revolution's promise of personalized medicine
miniaturization and multiplexed bioassays
The advent of non-invasive tools
New technologies applied to cancer diagnostics Overview
new platforms for analysis by mass spectrometry
chromosome next-generation sequencing " br /> RNA - ribonucleic acid
in vitro / in vivo mix
CHAPTER FIVE: Global Market Analysis background
for segments of the regional cancer diagnosis of corporate and product
Screening has lost its appeal? Cancer-specific tests
Bladder cancer Breast cancer Cervical cancer
lung cancer
Cancer Cancer of the Ovarian Cancer Prostate
CHAPTER SIX: Testing of cancer in the DIV segments (segment analysis)
cancer diagnosis and markets IVD
test market in cancer clinical chemistry
The market for cancer immuno-tests, Laboratory &;
Fast Point-of-care
The market for cancer tests in histology / cytology stains
traditional Pap smear and HPV test fabrics
IHC / ISH
The market for tissue microarrays
The market for cancer tests in flow cytometry
to the market for circulating tumor cells in cancer diagnostics market
molecular tests cancer
The market for cancer tests in
Pharmacodiagnostics The market for biochips and tables in the diagnosis Cancer
The Commercial Court of Outlook for the diagnosis of cancer
CHAPTER SEVEN: Conclusions and Policy Implications Conclusions
Conclusion 1 implicitly
2 implied Conclusion: Conclusion 4
Conclusion implicit implicitly
5 Conclusion 6:
Requirements unmet market needs unmet unmet need for # 1
# 2 # 3 unmet needs
CHAPTER EIGHT: The leading group of companies DIV and investment in cancer diagnosis
Abbott Diagnostics Molecular Diagnostics Molecular Histology
immunoassays Beckman Coulter Inc.
Flow Cytometry FOB Becton, Dickinson and Company (BD)
histology bioMérieux Inc. Bio-Rad Laboratories Inc.
Dako A / S
Fujirebio Diagnostics, Inc. " br /> Gen-Probe Inc..
Hologic, Inc.
Histology HPV Inverness Medical Innovations
Ortho Clinical Diagnostics QIAGEN NV
Roche Diagnostics Indianapolis, IN www. Recent History roche.com revenues ($ millions)
histology immunoassay PCR
search for Siemens Medical Solutions Diagnostics
In Vivo Molecular Sysmex Corporation
CHAPTER NINE: The status quo in the diagnosis of cancer AdnaGen
Agendia BV Diagnostics AMDL, Inc. (ADI)
American Diagnostica Inc.
Aperio Technologies, Inc.
AviaraDx Asuragen, Inc.
binding site (The) Ltd
BioCurex Inc. BioGenex Laboratories, Inc.
BioImagene Bio-Reference Laboratories, Inc. Biotage AB
bioTheranostics BioView Ltd
Celera Diagnostics China Medical Technologies, Inc.
Cisbio Bioassays
Clarient Inc. (formerly Chromavision)
Clinical Data, Inc.
CytoCore, Inc. DxS Ltd
Epigenomics AG Genetix Applied Imaging
Genomic Health, Inc. Genzyme Genetics
HistoRx Health Discovery Corporation, Inc.
Ikonisys, Inc.
International Genetics Inc br
Ipsogen SA Lab21 Healthcare
Laboratory Corporation of America Holdings (LabCorp)
Life Technologies Monogram Biosciences, Inc.
MTM Myriad Genetics, Inc. />
OncoVista innovative therapies, Pathwork Diagnostics Inc.
Therapeutics accuracy Prometheus Laboratories Inc., Quest Diagnostics
Response Genetics, Inc.
Rosetta Genomics Ltd. Sequenom Inc. Transgenomic
Veridex, LLC
Vermillion Inc. Zila, Inc.
CHAPTER TEN: new entrants and new products
Developers 20/20 Gene Systems, Inc.
454 Life Sciences Corporation
Acrometrix Corporation (. Life Tech)
Acupath Laboratories, Inc.
Advalytix Affymetrix Allegro Diagnostics, Inc. " br />
Althea Technologies, Inc.
Amorfix Life Sciences Ltd
Arbor Vita Inc ArcticDx Inc />
ARRAYIT Diagnostics Inc. AVEO Pharmaceuticals, Inc.
Axela, Inc.
Baypoint Biosystems, Inc.
Biodesix, Inc.
Biologix Diagnostics, LLC
biomarkers Strategies, LLC BIOMOD
BioMosaics bioprospecting NB, Inc. (BPNBI)
Bioserve Biosystems International SAS (BSI)
BioTrove, Inc.
Cambridge Research & Instrumentation, Inc. (CRI)
CANGEN Biotechnologies, Inc. Caris Diagnostics
Castle Biosciences Inc.
cell Celerus Diagnostics
CeMines Biosciences, Inc.
Cepheid Inc. ChromoCure Chronix Biomedical Inc.
Clinical Genomics Pty Ltd
CombiMatrix Molecular Diagnostics (CMDX)
Comprehensive Cancer Cell (CCC) Diagnostics Inc. Compugen Ltd.
Correlogic Systems, Inc. CS-
Keys, Inc., deCODE Genetics Inc.
---
DiagnoCure DiaGenic ASA -
Diagnoplex diagnostic Biosystems Company
DNA Direct, Inc.
skill Diagnostics EDP Biotech Corporation Plc Epistem
Exact Sciences Corp.
Exiqon A / S ExonHit
Diagnostics Inc. exosomes /> Expression Pathology Inc.
Falcon Genomics, Inc.
FASgen Diagnostics, LLC
Fluxion Biosciences Foligo Therapeutics, Inc.
Gastrocor GENELEX Inc.
new gene Limited
Genoptix Diagnostics iKaryos
Illumina Technologies Inostics INTERNATIONAL BV GmbH
bioPROBE intrinsic Inc.
Diagnostic Invirion, LLC
InVivoScribe Technologies Iris Biotechnologies Inc.
IRIS International, Inc.
MabCure Macro Array Technologies Inc., LLC
MagArray Inc. Martell Biosystems, Inc.
biogenic Med, Inc. ( MBI)
medical prognosis Institute Metabolon, Inc.
miraculin Inc. MolecularMD Corp.
Neogenix Oncology, Inc. NextGen Sciences
Nuvera Biosciences AB OLINK
Oncimmune LLC OncoMethylome SA
Q-ITY Orion Genomics
Oxford BioTherapeutics Pacific Edge Biotechnology Ltd (ILL)
PhotoCure ASA Power3 Medical Products, Inc. Prediction Sciences
Predictive Biosciences Inc. PrognosDx Health
Provista Life Sciences LLC
Rubicon Genomics, Inc.
Rules-Based Medicine, Inc. (RBM)
Saladax Biomedical, Inc. (SBI)
SensiGen LLC Sienna Cancer Diagnostics Signature Genomic Laboratories
, LLC
Skyline Diagnostics BV Singulex Inc.
Source MDx Soar biodynamics, Ltd. Strategic Diagnostics Inc.
Synergenz Bioscience Ltd Targeted Molecular Diagnostics (TMD)
Theranostics Health (TH)
TrimGen Inc. TrovaGene, Inc.
Vitatex Inc. WaferGen Biosystems, Inc.
Xceed Molecular (formerly MetriGenix Corporation)
Technologies Ltd. Zetiq Automobile Electronics & 4-stroke engines book explains the vehicle technology, electronic engine management, diagnostic and testing procedure as well as function and operation principle of each engine component on new automobiles generation with overview Automobile Electronics & 4-stroke engines
